Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients.

Cailleteau A, Sargos P, Saad F, Latorzeff I, Supiot S

Open source

DOI
10.3389/fonc.2021.780507
Published
2021
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.780507,
  title = {Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients.},
  author = {Cailleteau A and Sargos P and Saad F and Latorzeff I and Supiot S},
  year = {2021},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2021.780507},
  url = {https://doi.org/10.3389/fonc.2021.780507}
}

RIS

TY  - JOUR
TI  - Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients.
AU  - Cailleteau A
AU  - Sargos P
AU  - Saad F
AU  - Latorzeff I
AU  - Supiot S
PY  - 2021
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2021.780507
UR  - https://doi.org/10.3389/fonc.2021.780507
ER  - 

APA

A, C., P, S., F, S., I, L., & S, S. (2021). Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients.. Frontiers in oncology. https://doi.org/10.3389/fonc.2021.780507

Source records